Abstract.-The binding of cyclic 3',5'-adenosine monophosphate (cyclic AMP) within the adrenal cortical cell was studied. Cyclic AMP binds specifically to a protein which is associated predominantly with the microsomal fraction of the cell.
Introduction.-Previous studies suggest that adrenocorticotropic hormone (ACTH) stimulates adrenal corticosteroid production by a mechanism involving protein synthesis. Since the steroidogenic response of the adrenal cortex to ACTH is blocked by antibiotic inhibitors of protein synthesis but not by inhibitors of RNA synthesis, it was hypothesized that ACTH stimulates steroidogenesis by a mechanism involving the activation of protein synthesis at the level of the translation of stable messenger RNA.1-4
Because ACTH activates adenyl cyclase at the plasma membrane of the adrenal cell, resulting in increased formation of cyclic 3',5'-adenosine monophosphate (cyclic AMP),' and because cyclic AMP elicits the same steroidogenic response from the adrenal cortex as ACTH,6 it has been proposed that cyclic AMIP is the intracellular mediator of ACTH action. 8 In line with the action of ACTH described above, cyclic AMP appears to induce steroidogenesis by activating protein synthesis at the level of translation of messenger RNA, while the stimulation of the formation of cyclic AMP by ACTH is not dependent upon protein synthesis. 7 Despite the unequivocal evidence that cyclic AMP induces steroidogenesis, the mechanism of this action of the nucleotide is entirely unknown. Thus, in an attempt to elucidate the early molecular events of cyclic AMP, the binding of the nucleotide within the adrenal cell has been studied. The present investigation indicates that cyclic AMP binds specifically to a protein located predominantly within the soluble cytoplasmic and microsomal fractions of the adrenal cell.
Experimental Procedure.-Tissue preparation and subcellular fractionation: In all experiments, bovine adrenal glands were used unless otherwise noted. The adrenal glands were obtained from the local abbatoir on ice; the cortex was removed and homogenized 1:2 (w/v) in cold Littlefield's medium.9 Rat adrenal glands, when used, were quartered and handled identically. Nuclei were l)rel)ared by a modification of the technique of Blobel (Table 2 ). Heating at 500 for 15 minutes also markedly diminished binding, while ribonuclease treatment (50-1000 Pg/ml) had no effect on the binding of cyclic AMP (Table 2 ).
The data indicate that a substance which is at least part protein binds cyclic AMP and is associated with the microsomal fraction of the adrenal cortex.
Comparison of the cyclic AMP-binding protein from the microsomal and soluble fractions: Although the cyclic AMP-binding protein from the microsomal fraction demonstrated the highest specific activity, the bulk of the binding material of the cell was present, together with the greatest quantity of protein in the supernatant fraction (Table 1) . Therefore, to compare the binding proteins derived from microsomal and soluble fractions, analyses of the fractions at various stages of purification were performed by sucrose gradient sedimentation."4 As depicted in Figure 1 , the sedimentation profiles of the binding protein eluted from microsomes and from the soluble fraction were identical. In the studies, the binding protein consistently sedimented between ovalbumin and purified hemoglobin at 4S. Cyclic AMP-binding protein obtained from rat adrenals was similarly analyzed and observed to sediment identically. Also, similar to the microsomal material, the binding protein from the soluble fraction was inactivated by trypsin, protease, and heat, and was unaffected by RNase and DNase. The cyclic AMP-binding protein obtained from the microsomal and soluble fractions behaved similarly throughout the entire purification procedures described subsequently. Hence, the binding proteins from the microsomal and soluble fractions were considered to be identical. Because a greater quantity was present in the soluble fraction, this was used in the following studies.
Binding affinity: Equilibrium in the dialysis systems used was obtained by 16 hours at 5-80C. The study shown in Figure 2 63, 1969 Binding, once established, was poorly reversible. After 96 hours of dialysis against buffer alone, only 25 per cent of the bound cyclic AMP had been released. At the end of 96 hours, an aliquot containing the protein binding material was dialyzed against H3-cyclic AMP in TTM buffer. This revealed a similar estimate of binding, suggesting that the binding protein was stable for at least this period of time.
Recovery: Since the assay for the binding of cyclic AMP was entirely dependent upon the determination of radioactivity, it was essential to demonstrate that, under the conditions of the experiment, the radioactivity actually represented the cyclic nucleotide. Cyclic AMP, therefore, was recovered from the binding protein by the procedure outlined in Methods. After being bound to the protein for up to 48 hours, at least 90 per cent of the radioactivity chromatographed with cyclic AMP, suggesting that in binding to the protein cyclic AMP was not metabolized, and the structure of the molecule remained unaltered.
Specificity: In order to test the specificity of the binding protein for cyclic AMP, a variety of nucleotides were added to the dialysate, and their ability to compete with cyclic AMP for binding sites was determined (Table 3 ). None of the compounds other than cyclic AMP stimulates adrenal steroidogenesis in physiologic concentrations. The results indicate that the binding protein is relatively specific for cyclic AMP. Unlabeled cyclic AMP effectively competed with the labeled form for binding sites. The only other nucleotide which competed, though less effectively than cyclic AMP, was cyclic 3',5'-guanosine monophosphate (GMP). Increasing quantities of cyclic GMP displaced labeled cyclic AMP from the binding protein in a linear and parallel fashion to the displacement obtained with unlabeled cyclic AMP; however, cyclic GMP was 100-fold less efficient.
Purification: By using equilibrium dialysis to assay cyclic AMP binding, purification procedures of the cyclic AMP-binding protein were followed as given in Table 4 . As described above, the binding proteins derived from the soluble fraction and from the eluate of microsomes behaved similarly. Approximately a 100-fold purification of the binding proteins from both sources was obtained by the procedures listed in Table 4 . At each step of purification, aliquots of protein were assayed for binding activity by equilibrium dialysis as described in Table 1. Discussion.-Studies made with inhibitors of protein and RNA synthesis in the adrenal indicated that cyclic AMP stimulates steroidogenesis by a mechanism involving the modulation of the translation of messenger RNA.,7 The possibility that cyclic AMP is an inducer of protein synthesis is suggested by recent reports of nucleotide stimulating protein synthesis in rat liver and rat uteri, '6 17 modifying the release of newly synthesized proteins from rat liver ribosomes,18 and inducing specific enzyme synthesis in E. coli. 19 The present investigations disclose an adrenal cortical protein that specifically binds cyclic AMP. The high specific activity of binding remaining with the microsomal fraction after repeated washing indicates that the binding protein is associated with the microsomes. Because deoxycholate diminished binding in all fractions, the binding of cyclic AMP to the ribosomal fraction was difficult to evaluate. Equilibrium dialysis methods indicate a noninteracting binding site for cyclic AMP over the concentration range used.29 Studies using closely related nucleotides as competitors demonstrate that the site is specific for cyclic AMP. The partial competition by cyclic 3',5'-GMP but lack of competition by adenine nucleotides suggests that at least part of the specificity resides in the cyclic 3',5' ring.
In higher organisms the microsomes are involved in protein synthesis. However, in addition to the polyribosomes bound to endoplasmic reticulum, the organelle contains many enzymes and proteins which are bound nonspecifically to the microsomal complex. Therefore, it is essential to point out that the binding of a protein to the microsomal fraction fails to indicate a physiological function for the macromolecule. Nevertheless, in bacteria that contain ribosomes unassociated with endoplasmic reticulum, specific protein factors have been isolated that bind to ribosomes, and these factors have been shown to be involved with the ribosomal translation of messenger RNA.2022 Also, in higher organisms the endoplasmic reticulum may be involved with protein synthesis.23 However, if a specific role is to be assigned to the cyclic AMP-binding protein in adrenal protein synthesis, its function in the protein synthetic mechanism must first be demonstrated.
It is of interest that in E. coli, where the induction of the enzymes of the lactose operon occurs by an action at the level of the gene, Gilbert and Muller-Hill isolated the lactose repressor protein by its binding to an inducer, isopropylthiogalactoside; this repressor protein was then shown to bind to the operator region of the lactose operon DNA. 24 In contrast, in the adrenal gland where messenger RNA seems to be relatively stable' and where evidence suggests that cyclic AMP stimulates protein synthesis by acting at the level of translation of messenger RNA, the hypothetical inducer, cyclic AMP, binds to a protein, which is bound to the microsomal fraction.
The demonstrated recovery of cyclic AMP indicates that the nucleotide is not a substrate of the binding protein. Perhaps the action of cyclic AMP on the binding protein is similar to that of the cyclic nucleotide on various enzymes, i.e., to alter function, presumably by modifying the macromolecular structure.25-28 The association of this protein with microsomes suggests the hypothesis that the binding protein is involved in the machinery of protein synthesis and that the interaction of cyclic AMP with the protein results in the cyclic AMP-mediated activation of protein synthesis at the level of the translation of messenger RNA. In 
